Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival

APL Bioengineering(2020)10.1063/1.5142559Source: DataRank Database

Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival is a research paper published in APL Bioengineering (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.45)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Matthew W. Bradley ORCID,Karen Devine,Jay Bowen ORCID,Sara E. Coppens ORCID,Kristen Leraas ORCID

Live enrichment

PubMed:32478280 PMC:PMC7229984 OpenAlex:https://openalex.org/W3025993748

National Cancer Institute

Grant: U01 CA-202144

National Cancer Institute

Grant: K07 CA-230150

NIH Office of the Director

Grant: S10 OD-021644

NCI NIH HHS

Grant: K07 CA230150

NCI NIH HHS

Grant: U01 CA202144

NIH HHS

Grant: S10 OD021644

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5U01CA202144-05

Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics

National Institutes of Health

Grant: 1S10OD021644-01A1

From genomics to natural language processing: A protected environment for research computing in the health science

National Institutes of Health

Grant: 3K07CA230150-04S1

Subtyping Bladder Cancer: A Multi-omic, Exposure-informed, Genealogical Approach (MErGE)

Utah Science Technology and Research

FWCI

0.45

Citation Percentile

0.6%

Citation Trend

2020

2023

2024

2026

goldLicense: cc-by

journalhttps://aip.scitation.org/doi/pdf/10.1063/1.5142559

GOLDhttps://aip.scitation.org/doi/pdf/10.1063/1.5142559

publisherhttps://aip.scitation.org/doi/pdf/10.1063/1.5142559

publisherhttps://pubs.aip.org/aip/apb/article-pdf/doi/10.1063/1.5142559/13062215/026106_1_online.pdf

journalhttps://doi.org/10.1063/1.5142559

Fields of Study

Glioma Diagnosis and TreatmentCancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalitiesBiologyMedicine0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

ConcordanceGenomeProportional hazards modelHazard ratioOncologySurvival analysisUnivariatePopulationLog-rank testBiologyHuman genomeComputational biologyInternal medicineMedicineBioinformaticsGeneticsGeneConfidence intervalStatisticsMultivariate statisticsMedical technologyArticlesR855-855.5TP248.13-248.65Biotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being